Showing results (161-170 of 292) with videos related to
Sort By:
Pageof 30
Gynecologic and Obstetric Investigation|December 17, 2010
Endometriosis cost assessment (the EndoCost study): a cost-of-illness study protocolSteven Simoens, Lone Hummelshoj, Gerard Dunselman, et al.Orphanet Journal of Rare Diseases|October 18, 2013
Clinical evidence for orphan medicinal products-a cause for concern?Eline Picavet, David Cassiman, Carla E Hollak, et al.Reproductive Biomedicine Online|November 26, 2013
What is the societal burden of endometriosis-associated symptoms? a prospective Belgian studySarah Klein, Thomas D'Hooghe, Christel Meuleman, et al.Applied Health Economics and Health Policy|February 17, 2026
Ensuring Epidemiological Consistency in Risk-Stratified Cancer Screening Models: A Novel Approach Based on Flemish Breast Cancer ScreeningMax Lelie, Bo VandenBulcke, Nick Verhaeghe, et al.Applied Health Economics and Health Policy|October 13, 2019
Universal Mental Health Interventions for Children and Adolescents: A Systematic Review of Health Economic EvaluationsMasja Schmidt, Amber Werbrouck, Nick Verhaeghe, et al.Frontiers in Pharmacology|May 8, 2023
Biosimilar competition in European markets of TNF-alpha inhibitors: a comparative analysis of pricing, market share and utilization trendsElif Car, Arnold G Vulto, Mark Van Houdenhoven, et al.Frontiers in Pharmacology|May 6, 2021
Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape AnalysisYannick Vandenplas, Steven Simoens, Philippe Van Wilder, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 3, 2024
Mapping Health Technology Assessment Agency Approaches for Biosimilar Value Assessment: An ISPOR Special Interest Group ReportTeresa Barcina Lacosta, András Inotai, Catarina Lopes Pereira, et al.Expert Review of Pharmacoeconomics & Outcomes Research|April 26, 2025
A cost-effectiveness estimation of the Attempted Suicide Short Intervention Programme (ASSIP)Max Lelie, Riet Parmentier, Eva de Jaegere, et al.Journal of Pharmaceutical Policy and Practice|June 23, 2021
Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physiciansLiese Barbier, Yannick Vandenplas, Steven Simoens, et al.Pageof 30